| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |